Avatar
Forbes @forbes.com · Jersey City, New Jersey 🇯🇪· 6d

#Neuropsychiatry #DrugDevelopment #MentalHealth

Link Preview
www.forbes.com
Startup Organotics Fast Tracks Personalized Brain Drug Trials
Psychiatric drug development has a sobering statistic: nearly 96% of neuropsychiatric drugs fail, including many aimed at autism, bipolar disorder, and schizophrenia.